The median expression of the IGF2BP3 mRNA was the highest in B-ALL, Burkitt lymphoma, diffuse large B-cell lymphoma, follicular lymphoma, mantle cell lymphoma, and juvenile myelomonocytic leukemia, while the lowest median expressions were observed in hairy cell leukemia, hepatosplenic T-cell lymphoma, and adult T-cell leukemia (Figure 3A). This evidence concerns the gene IGF2BP3 and mantle cell lymphoma.